This site is intended for U.S. healthcare professionals only.

Terms and conditions

Terms and conditions

By using this website, you agree to be bound the terms and conditions set out below which are subject to change without notice to you:

1. Limited License and Use Aptevo Therapeutics Inc. ("Aptevo Therapeutics") grants you a limited license to display the contents of this website on your computer and print, download and use the materials on this website solely for non-commercial, personal or educational purposes, provided that the contents of the website are not modified in any way and that all copyright, trademark and other notices are maintained. You agree not to, or allow others to, directly or indirectly, attempt or actually disrupt, impair or interfere with, alter or modify this website or any of its content. Except as expressly provided herein, Aptevo Therapeutics does not grant any express or implied right to you under any of its patents, trademarks, copyrights or trade secret information. This website is for general information purposes only and is not intended to provide you with any personalized drug, health, medical or other professional advice. Any medical information provided should not be considered as a substitute for the advice of a physician, nor should it be used to diagnose a health problem or disease. Nothing on this website constitutes an offer to buy or sell products or services of Aptevo Therapeutics or any of its affiliated companies. All such products and services are subject to the terms and conditions of any applicable contracts and are available only in jurisdictions where they may be lawfully offered for sale.

2. Links This website contains links to other websites which websites are not maintained or controlled by Aptevo Therapeutics nor has Aptevo Therapeutics reviewed all of the websites that may link to this website. Aptevo Therapeutics does not warrant the accuracy, completeness, timeliness, non-infringement or fitness for a particular purpose of such websites or any information available through these links and disclaims any opinions expressed on such websites. Links on this website are provided for convenience only and are not to be construed as an endorsement by Aptevo Therapeutics of the products, services, advice or opinions or any other content of such websites.

3. Product and Scientific Information This website contains information about Aptevo Therapeutics' products which may not be available in a particular country, and if available, may have received approval or market clearance by applicable regulatory authorities for different indications or restrictions. Nothing on this website shall be construed as a solicitation or promotion for any product or for any indication for a product which is not authorized by the applicable laws of the country where the user resides. Scientific information that relates to unapproved products or unapproved uses of products is preliminary and investigative. No conclusions can or should be drawn regarding the safety or efficacy of such products. Only regulatory authorities can determine whether products are safe and effective for the uses being investigated. Healthcare professionals are directed to refer to approved labelling for products and not rely on information presented on this website. Prescribing information and product names may differ in various countries.

4. Trademarks Aptevo Therapeutics owns or has obtained the right to use by license or otherwise the trademarks used on or in connection with the product that it provides. "HepaGam B®" is a trademark owned by Aptevo Therapeutics. Trademarks are protected by U.S., Canadian, and foreign trademark laws. All rights reserved. The display of trademarks on this website shall not in any way be construed as an implied license to use such trademarks.

5. Copyright This website has been developed by and is the property of Aptevo Therapeutics. All information and materials contained on this website are protected by copyright, trademark and other intellectual property laws of the United States and other countries. Subject to the limited license to use this website as described herein, no person may copy, redistribute, reproduce or republish in any form, or link to this website or its contents in any manner whatsoever, including by way of hyperlinks or framing, unless that person has obtained the prior written consent of Aptevo Therapeutics. Any infringement of the rights of Aptevo Therapeutics may result in appropriate legal action.

6. E-mail Security The security of e-mail communication cannot be guaranteed at this time. Any person wishing to communicate or send information of a private or confidential nature to Aptevo Therapeutics is encouraged to do so by other means.

7. Privacy Aptevo Therapeutics' website does not collect any personal information about users of this website other than that which is specifically and knowingly provided by you. That personal information will not be transferred to any third party unless otherwise stated at the time of collection. Aptevo Therapeutics does collect and maintain statistics relating to the number of visits to the website, the types of browsers used and the Internet Protocol Address of the originator. This information is used only for internal purposes.

8. Changes. The content on this Website may be updated from time to time, but its content is not necessarily complete or up-to-date. Any of the material on the Website may be out of date at any given time, and we are under no obligation to update such material.

9. Disclaimer The content of this website is provided for informational and educational purposes only and is subject to modification without notice to you. While information posted on this website is believed to be reliable and accurate at the time of posting, Aptevo Therapeutics does not guarantee, represent or warrant that the information contained on this website is accurate, complete, reliable, verified or error-free. Aptevo Therapeutics makes no express or implied representations or warranties regarding the usability or condition of this website, that this website will operate uninterrupted or error-free, or that this website will operate in combination with any services or software used in connection therewith or that it shall be viewed consistently with all browser software or that any communication transmitted to or from this website is private, confidential or secure. APTEVO THERAPEUTICS EXPRESSLY DISCLAIMS ALL REPRESENTATIONS, WARRANTIES OR CONDITIONS, EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING, WITHOUT LIMITATION, THE WARRANTIES AND CONDITIONS OF MERCHANTABLE QUALITY AND FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, COMPATIBILITY, TIMELINESS, SECURITY OR ACCURACY, AND ANY REPRESENTATIONS, WARRANTIES OR CONDITIONS THAT MAY ARISE FROM A COURSE OF DEALING OR USAGE OF TRADE. WE WILL NOT BE LIABLE FOR ANY LOSS OR DAMAGE CAUSED BY A DISTRIBUTED DENIAL-OF-SERVICE ATTACK, VIRUSES OR OTHER TECHNOLOGICALLY HARMFUL MATERIAL THAT MAY INFECT YOUR COMPUTER EQUIPMENT, COMPUTER PROGRAMS, DATA OR OTHER PROPRIETARY MATERIAL DUE TO YOUR USE OF THE WEBSITE OR ANY SERVICES OR ITEMS OBTAINED THROUGH THE WEBSITE OR TO YOUR DOWNLOADING OF ANY MATERIAL POSTED ON IT, OR ON ANY WEBSITE LINKED TO IT.

10. Limitation of Liability YOU ASSUME FULL RESPONSIBILITY FOR RISK OF LOSS OF ANY NATURE WHATSOEVER RESULTING FROM YOUR USE OF THIS WEBSITE. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, YOU ACKNOWLEDGE AND AGREE THAT NONE OF APTEVO THERAPEUTICS OR ANY OF ITS AFFILIATES, OR ANY OF THEIR DIRECTORS, OFFICERS, EMPLOYEES OR AGENTS SHALL BE LIABLE TO YOU FOR LOSS OF DATA, COMPUTER TIME OR ANY LOSS OR DAMAGE OF ANY NATURE WHATSOEVER ARISING OUT OF OR ATTRIBUTABLE IN ANY MANNER WHATSOEVER TO YOUR USE OR INABILITY TO USE THIS WEBSITE FOR ANY REASON WHATSOEVER OR TO ANY ACTION OR INACTION ON THE PART OF APTEVO THERAPEUTICS OR FOR ANY DIRECT, INDIRECT, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, EVEN IF APTEVO THERAPEUTICS HAS BEEN ADVISED OF THE POSSIBILITY THEREOF, INCLUDING BUT NOT LIMITED TO LOST PROFITS, LOST OPPORTUNITIES OR BUSINESS REVENUES, LOSS OF GOODWILL, OR FAILURE TO REALIZE EXPECTED SAVINGS.

11. General Provisions These terms and conditions shall be governed by the laws of the State of Washington and the Federal laws of the United States applicable therein. You agree that any legal actions arising from this website and these terms and conditions must be commenced in the courts of the State of Washington. These terms and conditions are binding on you, your heirs, executors, administrators, legal representatives, successors and assigns. No waiver of by the Company of any term or condition set forth in these Terms of Use shall be deemed a further or continuing waiver of such term or condition or a waiver of any other term or condition, and any failure of the Company to assert a right or provision under these Terms of Use shall not constitute a waiver of such right or provision. If any provisions of these terms and conditions are determined to be invalid or unenforceable, everything else herein shall continue in full force and effect. Unless specified otherwise, dollar amounts are in U.S. dollars. You requested that these terms and conditions and any related documents be in English.

Expand

Indications

HepaGam B® [Hepatitis B Immune Globulin Intravenous (Human)] is an intravenous immune globulin indicated for the following:

  • Prevention of Hepatitis B recurrence following liver transplant in HBsAg-positive liver transplant patients

  • Post-exposure prophylaxis including:

    • Acute exposure to HBsAg-positive blood, plasma, or serum (parenteral exposure, direct mucus membrane contact, oral ingestion, etc.),
    • Perinatal exposure of infants born to HBsAg-positive mothers,
    • Sexual exposure to HBsAg-positive persons, and
    • Household exposure to persons with acute HBV infection.

Important Risk Information

CONTRAINDICATIONS: Individuals known to have severe, potentially life-threatening reaction to human globulin preparations should not receive HepaGam B® or any other immune globulin (human). Individuals who are deficient in IgA may have the potential to develop IgA antibodies and have severe, potentially life-threatening allergic reactions.

For post-exposure prophylaxis indications, HepaGam B® must be administered intramuscularly only. In patients who have severe thrombocytopenia or any coagulation disorder that would contraindicate intramuscular injections, HepaGam B® should be given only if the expected benefits outweigh the potential risks.

WARNINGS and PRECAUTIONS: HepaGam B® [Hepatitis B Immune Globulin Intravenous (Human)] is a sterile solution of gamma globulin (IgG) made from human plasma. Products made from human plasma may carry a risk of transmitting infectious agents, eg, viruses and, theoretically, the Creutzfeldt-Jacob disease (CJD) agent.

Thrombotic events have been reported in association with the use of immune globulins. Patients at risk include those with a history of atherosclerosis, multiple cardiovascular risk factors, advanced age, impaired cardiac output, coagulation disorders, prolonged periods of immobilization, and/or known/suspected hyperviscosity.

The maltose contained in HepaGam B® can interfere with some types of blood glucose monitoring systems. Only testing systems that are glucose-specific should be used in patients receiving HepaGam B®. This interference can result in falsely elevated glucose readings that can lead to untreated hypoglycemia or to inappropriate insulin administration, resulting in life-threatening hypoglycemia.

Liver transplant patients should be monitored regularly for serum anti-HBs antibody levels.

Certain adverse drug reactions may be related to the rate of infusion. The recommended infusion rate must be closely followed. Patients must be closely monitored and carefully observed for any symptoms throughout the infusion period and immediately following an infusion.

The most common adverse drug reactions observed in clinical trial subjects were hypotension and nausea (2% of clinical trial subjects).

For product inquiries about HepaGam B®, call (877) 437-2426.

Please see full Prescribing Information for full prescribing details.